Trading Update

Provexis PLC
06 April 2006

                                  PROVEXIS PLC
                         ('Provexis' or the 'Company')

                                 Trading Update

Provexis, the nutraceutical company that develops scientifically-proven
functional and medical foods, issues a trading update for the year ended 31
March 2006.

The Company's lead product Sirco(TM) was launched in Sainsbury's, Waitrose and
Tesco on 2 January 2006, 26 January 2006 and 4 February 2006 respectively.
Sales, operating costs and the cash position for the year ended 31 March 2006
are in line with expectations.

Sirco(TM) is the first heart health product to contain the patented 
Fruitflow(TM) technology. Fruitflow(TM) works by reducing blood platelet 
aggregation ('thinning the blood'), a significant contributing factor to a 
thrombosis (internal blood clot) which can lead to heart attack or stroke.

Licensing talks are on-going with major food and beverage corporations regarding
the global licensing of the Fruitflow(TM) technology across different 
application areas. As previously announced on the 9 March 2006, an independent 
Expert Panel in the United States affirmed that Fruitflow(TM) was Generally 
Recognised as Safe ('GRAS'). Together with the existing clearance in the EU, 
this development paves the way for products containing Fruitflow(TM) to be 
marketed across two principal target markets.

In addition to Fruitflow(TM), the Company continues to develop its product
pipeline with two other technology platforms which are intended to underpin new
product launches in 2007 and 2008. The first of these products will be a
functional beverage, containing a glucosinolate-enriched broccoli extract for
reducing the risk of specific types of cancer. The second product will be a
medical food, based on a patented extract from plantain fruit, designed to
extend remission time in patients with Crohn's Disease.


For further information please contact:

Provexis plc
Dr Stephen Franklin                          020 8392 6631


Bell Pottinger Corporate & Financial
Emma Kent/Victoria Geoghegan                 020 7861 3232








                      This information is provided by RNS
            The company news service from the London Stock Exchange